You will master, thanks to TECH, the latest therapeutic procedures to intervene in a personalized way in the Cardiac Rehabilitation of patients with Acute Coronary Syndrome”  

In recent times, medical sciences have devoted multiple research studies to find more complete and comprehensive diagnostic and treatment methods against ischemic heart disease. Therefore, powerful tools such as Echocardiography, Coronary Angiography or Nuclear Stress Ischemia Test have evolved. Likewise, complex therapeutic methods such as coronary angioplasty with stenting, radiofrequency ablation therapy and coronary revascularization without extracorporeal circulation have also appeared. Keeping up to date on these and other advances, such as cell therapy, can be cumbersome for specialists. In particular, the development of this practice becomes more complex in a context where academic programs with high theoretical load and that do not pay attention to the development of practical competencies prevail.

TECH wants to leave behind this unsatisfactory context by designing a study modality that adjusts to the training needs of the cardiologist. Therefore, this Hybrid professional master’s degree in Acute Coronary Syndrome has two differentiated stages. In the first one, the physician will have 1,500 hours of theoretical learning from an interactive platform. You will also use innovative teaching methods such as Relearning to assimilate new content quickly and flexibly. Until you complete this preparation phase, you will not have to worry about pre-established schedules or rigid evaluation chronograms. At any time, you will be free to study from the comfort of any device connected to the Internet. 

Upon completion of this theoretical training, the professional will have at their disposal the possibility of a practical and face-to-face internship at a state-of-the-art hospital center. Their transit through these institutions, which lasts 3 weeks, will allow them to apply the procedures learned directly in real cases. In addition, you will be guided by internationally renowned experts who will supervise your academic progress while facilitating the management of complete tools that today distinguish the evolution and development of protocols on Acute Coronary Syndrome.

Make the most of this opportunity to surround yourself with expert professionals and learn from their work methodology"

This Hybrid professional master’s degree in Acute Coronary Syndrome contains the most complete and up-to-date scientific program on the market. The most important features include: 

• Development of more than 100 clinical cases presented by medical professionals with extensive experience in the management of Acute Coronary Syndrome
• The graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice
• Comprehensive systematized action plans for the main pathologies
• Presentation of practical workshops on procedures diagnosis, and treatment techniques
• An algorithm-based interactive learning system for decision-making in the clinical situations presented throughout the course
• Practical clinical guides on approaching different pathologies 
• All of this will be complemented by theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection 
• Furthermore, you will be able to carry out a clinical internship in one of the best hospital centers  

Complete the 3 weeks of face-to-face practice of this Hybrid Professional Masters and develop by yourself complex, minimally invasive Revascularization procedures in your patients with Acute Coronary Syndrome”

In this Hybrid professional master’s degree, with a vocational nature and blended learning modality, the program is aimed at the development of Medical professionals who require a high level of qualification. The contents are based on the latest scientific evidence, and oriented in an educational way to integrate theoretical knowledge into practice, and the theoretical-practical elements will facilitate knowledge update and decision-making in patient management. 

Thanks to its multimedia content developed with the latest educational technology, TECH will allow the professional to learn in a contextual and situated learning environment, i.e., a simulated environment that will provide immersive learning programmed to train in real situations. This program is designed around Problem-Based Learning, whereby the physician must try to solve the different professional practice situations that arise during the course. For this purpose, the students will be assisted by an innovative interactive video system created by renowned and experienced experts.

This curriculum is all you need to get up to speed on the latest therapeutic protocols in hospital coronary units”

Update your skills in the approach to patients with obstructed arteries through complex care methodologies such as coronary angioplasty with stenting”

The syllabus of this Hybrid Professional Master, composed of 10 didactic modules, carefully analyzes ischemic heart disease, its incidence and impact on the world population. At the same time, it examines the most recently implemented diagnostic tools in this health field, as well as those devices that facilitate therapeutic strategies such as coronary angioplasty with mesh or revascularization surgery, without extracorporeal circulation. The entire program is supported by didactic resources such as interactive summaries, videos and infographics that will help the physician to become up to date on all the skills necessary to undertake these kinds of procedures. 

TECH implements for the first phase of this degree program academic methodologies such as Relearning of great value for the fast and flexible assimilation of the most up to date and complex content” 

Module 1. Ischemic Heart Disease: A Global Issue

1.1. Ischemic Heart Disease. Normal Coronary Blood Flow and Coronary Artery Blockage
1.2. Cardiovascular Disease: the Leading Cause of Mortality in the Developed World Epidemiological Transition
1.3. CV Disease as a Cause of Mortality in Spain and Latin American Countries
1.4. Atherosclerosis: Phases
1.5. ACS Pathophysiology At-Risk Myocardium Anatomic Pathology Findings in ACS
1.6. Non-Atherosclerotic Causes of ACS
1.7. Classic Risk Factors for Atherosclerosis: Hypercholesterolemia and Smoking
1.8. Classic Risk Factors for Atherosclerosis: Age and Sex, Diabetes and Arterial Hypertension
1.9. New Atherosclerosis Risk Factors

Module 2. Clinical Presentation of Coronary Syndromes and Classification NSTEACS 1: Epidemiology. Pathophysiology and Classification

2.1. Forms of presentation of coronary artery disease: chronic and acute coronary syndromes
2.2. Operational Classification of ACS Based on ECG, Non-ST Segment Elevation ACS Epidemiology
2.3. Pathophysiology and Correlation with Anatomic Pathology
2.4. Unstable Angina and Non-Q AMI, Clinical Features
2.5. ECG and Non-ST Segment Elevation ACS
2.6. Complementary Diagnostic Laboratory Tests and RXT in Non-ST Segment Elevation ACS
2.7. Risk Stratification, Thrombotic Risk Scales
2.8. Risk Stratification, Hemorrhagic Risk Scales
2.9. Variant Angina and Coronary Vasospasm Clinical Features
2.10. Vospasm Provocation Tests Treatment and Prognosis of Vasospasm

Module 3. NSTEACS 2: Imaging and Ischemia Detection Tests 

3.1. Differential Diagnosis of TD in the Emergency Department
3.2. Imaging Protocols in Emergency Department TD Units Assessment and Algorithm for the Diagnosis of Patients with TD in the Emergency Department
3.3. Value of Transthoracic Echocardiography in the Assessment of the Patient with Suspected NSTEACS Use of POCUS
3.4. Ergometry and Effort Echo/Stress Echo in the Patient with TD in the Emergency Department Indications and Technique
3.5. Isotopic Perfusion Tests Indications and Technique
3.6. Coronary CT in the ED patient with TD Indications and Technique
3.7. Role of MRI in NSTEACS and Patients with Chest Pain Indications and Technique
3.8. Anatomical Approach vs. Functional in the Diagnostic Assessment of the Patient with Chest Pain
3.9. Long-Term Follow-Up Using Imaging Techniques

Module 4. NSTEACS 3: Medical and Revascularization Treatment

4.1. General and Monitoring Measures
4.2. Anti-Anginal Drugs: Beta Blockers
4.3. Anti-Anginal Drugs: Nitrates and Calcium Antagonists
4.4. Planetary Antiaggregants Which Ones and For How Long?
4.5. Anticoagulant Drugs Which Ones, How Much and Why?
4.6. Indications for Coronary Angiography and Revascularization
4.7. When Is Surgical Revascularization Indicated and When Is Percutaneous Revascularization Indicated?
4.8. Percutaneous Revascularization Techniques
4.9. Surgical Revascularization Techniques

Module 5. NSTEACS 1: Clinical Picture, Presentation and Pre-Hospital and Emergency Assessment

5.1. Clinical Presentations of NSTEACS
5.2. Out-of-Hospital Sudden Death Causes and Prognosis
5.3. Assessment of the Patient with NSTEACS in the Pre-Hospital Phase and in the Emergency Department (Clinical and Physical Examination) Initial Risk Stratification
5.4. ECG in the Acute Phase of NSTEACS and Correlation with Coronary Anatomy
5.5. ECG with ST Elevation: Differential Diagnosis
5.6. Evolving ECG Pattern in NSTEACS
5.7. General Treatment Measures and Initial Monitoring, Why Is It Important?
5.8. Initial Pharmacological Treatment of NSTEACS: Oxygen Therapy, Nitrates, Beta-Blockers
5.9. Pre-Hospital Antithrombotic Therapy: When and with What?
5.10. Indications for Coronary Reperfusion: The Problem of Timing

Module 6. NSTEACS 2: Patient Management in the Hospital. Coronary Unit

6.1. Role of the Coronary Care Unit, the Value of Monitoring and General Early Treatment Measures General Measures
6.2. Patient Stratification and Risk Scales
6.3. Complementary Laboratory Tests
6.4. Lipid-Lowering Drugs and Treatment Goals
6.5. Antianginal Drugs in NSTEACS
6.6. Platelet Antiplatelet Aggregation in NSTEACS
6.7. Anticoagulation Indications Anticoagulants
6.8. Complications of NSTEACS: Chronic Heart Failure (CHF)
6.9. Complications of NSTEACS: Cardiogenic Shock, Medical Treatment and Mechanical Support
6.10. Mechanical Complications of NSTEACS: Cardiac Rupture, VSD and MI

Module 7. NSTEACS 3: TTE and Other Imaging Tests in Acute Patient Assessment and in the Hospital Phase

7.1. CXR in NSTEACS
7.2. Value of Transthoracic Echocardiography in the Patient with NSTEACS
7.3. Transthoracic Echocardiographic Assessment of Mechanical Complications of NSTEACS
7.4. Echocardiographic Assessment of the Patient with Heart Failure or Cardiogenic Shock
7.5. Usefulness of Imaging Techniques in the Prognostic Assessment of the Patient with NSTEACS Diagnostic Assessment of Residual Ischemia and Myocardial Viability
7.6. New Techniques for Myocardial Deformation in NSTEACS
7.7. MINOCA Causes and Prognosis
7.8. Usefulness of MRI in Patients With Myocardial Damage Without Epicardial Coronary Disease
7.9. Assessment of Myocardial Perfusion by Contrast Echocardiography Correlation with Angiographic Findings

Module 8. NSTEACS 4: Limitation of Infarct Size. Reperfusion Therapies

8.1. Myocardial Necrosis and Ischemia, the Problem of Ischemia Time
8.2. Strategies to Decrease Infarct Size: Fibrinolysis vs Primary Angioplasty
8.3. Fibrinolysis, Advantages, Disadvantages and Protocols
8.4. Primary Angioplasty Technique and Requirements
8.5. Stents: Types and Results Thrombus Extractors?
8.6. Antiplatelet and Anticoagulation Treatment During PCI
8.7. Long-Term Anti-Aggregation Treatment
8.8. The Problem of Antiplatelet Treatment in Patients Who Also Take Anticoagulant Drugs Protocols
8.9. Hemodynamic Support During Primary Angioplasty Available Methods and Results
8.10. Infarction Code Programs and Regional Reperfusion Networks

Module 9. NSTEACS Arrhythmias

9.1. Ischemia as a Cause of Arrhythmias: Mechanisms
9.2. NSTEACS Arrhythmias: EV, RIVA and TVNS (Meaning and Clinical Management)
9.3. Polymorphic and Monomorphic VT: Meaning and Treatment
9.4. VF and Out-of-Hospital Sudden Death in STEACS
9.5. Supraventricular Arrhythmias in NSTEACS
9.6. Antiarrhythmic Medication Used in STEACS
9.7. Cardioversion and Electrical Defibrillation: Protocols
9.8. Bradyarrhythmias and Blockages in STEACS Pacemaker Implantation Indications
9.9. Automatic Implantable Defibrillator: Indications, Results and Techniques
9.10. Cardiac Resynchronization, Indications and Outcomes

Module 10. ACS Secondary Prevention. Cardiac Rehabilitation Programs

10.1. Optimization of Medical Treatment after ACS
10.2. Diet and Obesity Management
10.3. Prescription and Types of Exercise
10.4. Control of Arterial Hypertension before and after ACS
10.5. Dyslipidemia Control Before and After ACS
10.6. Smoking Control
10.7. Diagnosis and Management of Diabetes in Ischemic Heart Disease
10.8. Cardiac Rehabilitation Programs: Evidence, Phases, Components and Process of Care
10.9. Telemedicine in Cardiac Rehabilitation
10.10. Continuity of Care after ACS and Cardiac Rehabilitation PHASE III Cardiac Rehabilitation

100% online, without timetables and with multiple interactive resources: this is the platform that TECH offers you for the theoretical learning of this Hybrid Professional Master”